India's gross domestic product spending on research and development is below the global average and expenditure should be increased to create an economy of scale, Minister of Science & Technology and Earth Sciences Kapil Sibal has said.
The Tata group has earmarked about Rs 1,000 crore (Rs 10 billion) for investment over the next four years in Advinus Therapeutics, a joint venture floated by it and ex-Ranbaxy research head Rashmi Barbhaiya.
Microsoft chairman and chief software architect Bill Gates will inaugurate the Digital Lifestyle 2005 to be organised in Bangalore by MAIT, the apex body representing the hardware, training and R&D services sectors of the IT industry in India.
We gauge the Pune market and finds that real estate developers are queuing up for a slice of India's next boom town.
Science-based products and services company DuPont said on Thursday it will invest Rs 200 crore (Rs 2 billion) to set up its first Knowledge Centre in India.
Automobile dealers' body FADA said the Budget lacked immediate demand boosters for the automobile industry.
Singapore-based MatrixView on Friday said it was in talks with Indian banks and hospitals for the implementation of its patent-pending digital content optimisation and compression technology.
India's R&D spend trebled in a decade, but China's has grown even faster
So far the coronavirus, which originated in the Chinese city of Wuhan, has infected more than 54 million people around the world and killed over 1.3 million others.
India is increasingly becoming an attractive destination for clinical research for pharma groups looking for faster and more efficient ways to test drugs for western countries
Drug maker Lupin Ltd on Thursday said it would acquire 51 per cent stake in Belgium-based Artifex Finance CVA for an undisclosed sum.
Thailand welcomed "knowledge workers" from India and is keen on a partnership with New Delhi in helping the South East Asian country
We believe that our R&D business has tremendous potential for growth and long-term profitability.
As remarkable as DRDO's contribution in containing and treating COVID-19 has been, its success over the last 15 months has been in its primary role of developing conventional defence equipment and technologies.
Utility vehicles major Mahindra and Mahindra is planning to pump in close to $100 million (around Rs 430 crore) in a dedicated facility to integrate its entire research and development efforts under one roof.
The central government will invest Rs 1,700 crore (Rs 17 billion) in setting up world-class automotive testing and R&D infrastructure with foreign collaboration.
Procter & Gamble, USA, has donated Rs 45 lakh (Rs 4.5 million) to the Indian Institute of Science, Bangalore to foster collaboration in the area of modelling for chemical and formulated systems.
US-based voice enabled SMS applications provider Bubble Motion will invest about Rs 25 crore (Rs 250 million) in setting up an R&D centre in India, besides increasing its headcount nine fold this year.
This is a one-year distance learning course.
Landing on an aircraft carrier deck is the ultimate and most daunting challenge for a fighter pilot. This takes India into a select group of nations -- the US, the UK, Russia, France, and China -- that have developed such jets.
SEL will also be setting up an innovation centre in Denmark, which will focus on concepts beyond design and development-related R&D.
The policy aims to create around 5,000 startups, including 10 global high-growth startups, and to create a minimum of 100,000 high skilled job creation, direct and indirect, in the startup ecosystem by 2023.
Bill Gates, chief architect of Microsoft Corporation, is expected to boost his company's investment plans in the country besides giving a fillip to its R&D activities.
SAS, global leaders in business intelligence solutions, on Friday announced setting up of its largest research and development centre in Pune, as it expects the Indian market to grow by 27 per cent and generate $87.4 billion worth business by 2009.
Domestic food companies, too, continue to bet on packaged foods.
Ranbaxy Laboratories has decided to separate the two areas of research and development - drug discovery and generics/NDDS/drug development - to achieve increased focus and rigour for success.